The aim of this study is to assess the long-term effect of mesenchymal stem cells (MSC) transplantation in a rat model of chronic myocardial infarction (MI) in comparison with the effect of bone marrow mononuclear cells (BM-MNC) transplant. Five weeks after induction of MI, rats were allocated to receive intramyocardial injection of 10 6 GFP-expressing cells (BM-MNC or MSC) or medium as control. Heart function (echocardiography and 18 F-FDG-microPET) and histological studies were performed 3 months after transplantation and cell fate was analyzed along the experiment (1 and 2 weeks and 1 and 3 months). The main findings of this study were that both BM-derived populations, BM-MNC and MSC, induced a long-lasting (3 months) improvement in LVEF (BM-MNC: 26.61 ± 2.01% to 46.61 ± 3.7%, p < 0.05; MSC: 27.5 ± 1.28% to 38.8 ± 3.2%, p < 0.05) but remarkably, only MSC improved tissue metabolism quantified by 18 F-FDG uptake (71.15 ± 1.27 to 76.31 ± 1.11, p < 0.01), which was thereby associated with a smaller infarct size and scar collagen content and also with a higher revascularization degree. Altogether, results show that MSC provides a long-term superior benefit than whole BM-MNC transplantation in a rat model of chronic MI.
INTRODUCTION
the potential for improvement in cardiac function. Different cell types (51) have been employed in animal models [reviewed in (53) ] with, importantly, bone marCardiovascular diseases are a leading health concern in Western countries (40) , with ischemia as the main row-mononuclear cells (BM-MNC) (37) , mesenchymal stem cells (21), and skeletal myoblasts undergoing clinimechanism for loss of cardiomyocyte (CM) mass and contractile force. In spite of new approaches and theracal trials (3, 35, 42, 45) . Although animal studies and phase I studies suggested a positive effect of these cell pies (9, 22, 25, 26, 34, 39, 57) , regeneration of the damaged tissue has not been successfully achieved, and compenpopulations, recently published randomized clinical trials have shown controversial results (42, 43) . Although sation of chronic hypertrophy is in most cases difficult, leaving heart transplantation as the only alternative for new long-term studies with larger patient groups are required in order to confirm these data, the use of other end-stage patients.
Stem cell application to the field of regenerative medcell types that could offer better chances to regenerate the infarcted heart may be a useful approach. icine offers new strategies to induce tissue repair and Bone marrow has been shown to contain several popCharacterization of MSC was performed by FACS and differentiation capacity. Cells were stained with antibodulations of stem cells like hematopoietic stem cells, endothelial progenitor cells, mesenchymal stem cells (MSC) ies against RT1A, RT1B, CD31, CD44, CD45, CD73, and CD90 (all purchased from BD, Madrid, Spain). For [reviewed in (32) ], and others with greater differentiation capacity like the multipotent adult progenitor cells osteogenic differentiation, cells were plated at 6000 cells/cm 2 in osteogenic media [αMEM with 10% FCS, (MAPC) (24) , the marrow-isolated multilineage inducible (MIAMI) cells (13) , or the very small embryonic-1% antibiotics, 10 mM β-glicerolphosphate (Sigma), 0.2 mM ascorbate-2-phosphate (Sigma), and 0.01 µM dexalike (VSEL) cells (30) . While the product obtained from a bone marrow aspiration contains some of these promethasone (Sigma)]. Condrogenic differentiation was performed with 200,000 pelleted cells suspended in congenitors, their proportion might be too low to exert any significant benefit in the setting of cardiac ischemia. It drogenic media [DMEM-high glucose (Invitrogen) with 1% antibiotics, 10 ng/ml TGF-β3 (R&D Systems, Minis thus logical to believe that enrichment of some of these populations in vitro could enhance the beneficial neapolis, MN, USA), 50 mg/ml ITS+Premix (BD), 40 µg/ml proline (Sigma), 500 ng/ml BMP6 (R&D Syseffects of BM-MNC transplantation. On the other hand, MSC have attracted much attention in the field given tems), 50 µg/ml ascorbate-2-P, and 0.1 µM dexamethasone]. For adipogenic differentiation, when cells reached their potential to transdifferentiate into suitable phenotypes (17, 19, 36) and also to exert paracrine actions upon 95-100% confluence, expansion media was replaced with adipogenic media [αMEM with 10% FCS, 1% anthe ischemic tissues (29, 38) . Moreover, their immunomodulatory properties (31) could exert a positive effect tobiotics, 50 µM indomethacin (Sigma), 0.5 mM IBMX (Sigma), and 1 µM dexamethasone]. All differentiation after transplantation into the heart by regulation of tissue inflammation (4) . On top of this, their in vitro processprotocols were maintained for 21 days. Analysis of cell differentiation was performed by histochemical staining ing is simple and even in humans renders sufficient amount of cells for an optimum treatment of the disease.
by Oil red O (adipogenic), Alizarin red (osteogenic), and toluidine blue (condrogenic) following previously deCurrently, although many studies have been performed with different stem cell preparations in myocarscribed protocols (62) . dial ischemia models, the lack of comparative studies Experimental Model makes it difficult to determine which population has a better regenerative effect. Moreover, bone marrow-de-A total of 115 female Sprague-Dawley rats (Harlan IBERICA S.L. Barcelona, Spain) underwent coronary rived stem cells have been mainly tested in acute models of myocardial infarction. Thus, in the current study we artery ligation of the left coronary artery as previously described (3). Only those animals that survived (n = 97) sought to compare the long-term putative beneficial effects of two stem cell populations derived from the BM:
and with a LVEF below 40% at 1 month post-MI were included in the study (n = 75). Five weeks after myocarfreshly isolated BM-MNC and bone marrow MSC in a chronic model of myocardial infarction. dial infarction induction, rats were reoperated by sternotomy and allocated to receive 10 6 cells per animal (total MATERIALS AND METHODS volume: 70 µl) of BM-MNC (n = 24), MSC (n = 25), or control medium (n = 26) in two points of the infarct borIsolation and Characterization of Cells der region. Due to the allogeneic origin of the cells, animals were daily immune-suppressed with cyclosporin A All eGFP cells (bone marrow) were isolated from 4-6-week-old Sprague-Dawley eGFP rats. Bone mar-(20 mg/kg/day, IP, Sandimmun, Novartis) from 2 days pretransplantation until sacrifice. Rate of survival over row cells were harvested from rat femurs and isolated by means of a Ficoll-Paque density gradient centrifugathe course of the experiment was over 98%. All experiments, including bone marrow cell isolation, were pertion. For BM-MNC transplantation, cells were washed and resuspended in culture media (DMEM, Invitrogen, formed in accordance with the principles of laboratory animal care formulated by the National Society for MedLeiden, The Netherlands) without supplements at a concentration of 10 6 ) and arteriolar area (µm 2 ) were quantified in a similar way after staining with anti-α-SMA-Cy3 in the fola secondary antibody anti-chicken IgY coupled to 655 nm emitting quantum dots were used following manulowing sections. Pictures were taken on a Nikon Eclipse E800 microscope equipped with epifluorescence optics facturer's instructions. Immunolabeling was performed with antibodies against α-smooth muscle actin (α-SMA) and digital images were analyzed using imaging software (Jay Image), or on a Zeiss LSM 510 META laser [mouse monoclonal antibody (mAb) diluted 1:1000 in TBS; Sigma, Madrid, Spain] coupled to Cy3, cardiac confocal microscope. The degree of fibrosis was determined by quantification of collagen deposition stained troponin T (cTT) (mAb, diluted 1:100 in TBS; Labvision), ventricular myosin (mAb diluted 1:2 in TBS; Bioby Sirius red as previously described (16 quantified in animals sacrificed 1 and 2 weeks after cell injection by counting PCNA-positive cells in sections For Sirius Red staining, sections were deparaffinized and immersed in Sirius Red (Sigma) for 90 min, differstained for GFP, PCNA, and a lineage-specific marker, either caveolin-1 for endothelium or α-SMA for myofientiated 2 min in HCl (Sigma) 0.01 N, dehydrated, and mounted in DPX. Hematoxylin-eosin staining was perbroblast or smooth muscle. Number of sections was the same as for macrophage density. All photographs were formed as detailed elsewhere (16) . Briefly, sections where stained in Ehrlich's hematoxylin (Sigma) for 7 taken on a Zeiss LSM 510 META laser confocal microscope. min, differentiated through water-HCl and Li 2 CO 3 solutions, immersed in eosin (Sigma) for 10 s, dehydrated, Echocardiographic Studies and mounted in DPX.
Animals were slightly anesthetized prior to study Electron Microscopy with 2% isoflurane (Forane, Lab. ABBOTT S.A, Madrid, Spain) in 100% O 2 gas and placed in the supine or For electron microscopy studies, six to eight animals per group were sacrificed and hearts were fixed with 4% lateral position on a warming pad for transthoracic twodimensional echocardiography, M-mode recordings, and paraformaldehyde 0.5% glutaraldehyde. Sections were postfixed with 1% osmium (30 min), rinsed, dehydrated, Doppler ultrasound measurements as previously described (3). Echocardiography was performed using a and embedded in araldite (Durcupan, Fluka). Semithin sections (1.5 µm) were cut with a diamond knife and Sonos 4500 ultrasound system (Philips) with a 12 MHz linear array transducer and Doppler measurement. Left Mann-Whitney test with Finner's correction of significance. Shapiro-Wilk test was used to verify that the data ventricular remodeling was assessed by measuring end systolic and diastolic volumes and diameters according had a Gaussian distribution, which justifies the use of a parametric test. Statistical analysis was performed with to the American Society of Echocardiology. The left ventricular ejection fraction was determined in parasterthe SPSS 11.0 software and differences were considered statistically significant when p < 0.05. nal short axes (41) and diastolic function was assessed by measuring E and A waves of the mitral filling pattern RESULTS by pulsed echo-Doppler technique in four-chamber apical views. Echocardiographic studies were performed at Cell Culture and Characterization baseline (before infarct), before cell transplantation, and at day 90 posttransplant by the same blinded investiga-MSC presented a typical spindle-shape in culture conditions. GFP expression was monitored during cultor. Measurements were done in three cycles and the mean value was obtained.
ture and before transplantation, ensuring that over 90% of the cells were positive (not shown In order to assess if cell therapy was capable of inducing a long-lasting improvement in a model of rat jection, animals were anesthetized with isoflurane, placed prone on the PET scanner cradle, and kept during the chronic MI, cardiac function and tissue metabolism were monitored by echocardiography and microPET, 3 months overall study under continuous influx of the anesthetic. A static 60-min study (sinogram) was acquired in a Moafter injection of BM-MNC, MSC, or control media. Artery ligation provoked a marked reduction of the left saic (Philips) small-animal dedicated imaging tomograph. Scanner efficiency normalization, dead time, and ventricular ejection fraction (LVEF) from baseline (72.23 ± 8.47%, mean ± SD) to preinjection (5 weeks decay corrections were applied during reconstruction. Images were reoriented for further processing and polar later) (27.82 ± 6.69%), which did not differ between all three groups. Compared to their preimplant values, both maps obtained using the specific cardiac imaging software package of the PET scanner. After reorientation of BM-MNC and MSC treatment induced a statistically significant improvement of left ventricular (LV) functransaxial images into short-and long-axis slices polar maps were generated and divided into 17 different ROIs.
tion (BM-MNC: 26.61 ± 2.01% to 42.61 ± 3.7%; MSC: 27.5 ± 1.28% to 38.8 ± 3.2% pretransplant and 3 months, Individual quantification of the 18 F-FDG uptake in each of them was calculated. The total number of counts obrespectively; p < 0.05), whereas animals injected with medium did not show any improvement in the cardiac tained for each of the ROIs was divided by its corresponding area to obtain counts per area unit. For each function (29.87 ± 2.84% to 28.1 ± 1.59%) (Fig. 2) . No significant differences were detected between both cell-PET study, the maximal value of the 17 ROIs was considered as 100% and the remaining data transformed treated groups (BM-MNC vs. MSC; p = 0.97), indicating no superior benefit from one or the other cell popuinto percentage values. All further calculations and statistical analysis were performed on these sets of rescaled lation. Analysis of polar maps including the whole left ventricle (the 17 cardiac segments) showed that MSCnumerical data.
treated animals had a significant improvement in cardiac Statistical Analysis metabolism compared with their preinjection parameters (72.15 ± 1.17% to 76.31 ± 1.1%; p < 0.01) (Fig. 3A) . All data are expressed as mean ± SEM or median (Q25; Q75). Comparisons for repeated measurements MSC treatment proved to have a positive effect not only in global tissue metabolism, but more importantly when were performed by ANOVA accompanied by Tukey's HDS for intergroup comparisons or Kruskal-Wallis and the analysis was restricted to the infarcted segments (7, 13, 16, and 17) as depicted by the significant increase myocardium of infarcted animals, and this number decreased to 1.33% (0.52; 2.14) at 2 weeks, were almost in their metabolism (46.8 ± 3.35% to 53.02 ± 3.55%, p < 0.05) (Fig. 3B, C) . On the contrary, BM-MNC injecnot detectable at 1 month, and disappeared at 3 months. On the other hand, presence of GFP-BM-MNC could tion did not have a significant effect in tissue metabolism (all segments: 70.87 ± 1.88% to 73.55 ± 1.88%; innot be detected even at 1 week posttransplant (Fig. 4E-H) . No positive signal was found on medium-injected farcted segments: 44.8 ± 4.3% to 50.4 ± 4.63%).
animals ( Fig. 4I-L) .
MSC Engraft in the Ischemic Tissue and Induce a
It is possible that, despite immunosuppression, the Reduced Inflammatory Reaction Than BM-MNC GFP antigen could be recognized by the macrophages, which in turn could react against the transplanted cells Cell fate was analyzed by immunohistochemical and immunofluorescence detection of GFP-positive cells at (33) . In order to study this, CD68 immunostaining was performed in animals sacrificed 1 week after transplant. 1 and 2 weeks and 1 and 3 months after their transplantation in the border zone of the infarct. We found large Intra-and peri-infarct sections were analyzed and, as depicted in Figure 5 , a strong macrophage infiltration was patches of GFP-positive cells at the injection site in rats treated with MSC 1 and 2 weeks after transplantation, found in BM-MNC-treated animals, both in the infarct (327.6 ± 49.67 positive cells/mm 2 , p < 0.01 vs. medium) but not from 1 month onwards (Fig. 4A-D) . Cell engraftment was quantified in MSC-treated animals as de- (Fig. 5A-D 18 F-FDG uptake was evaluated by microPET before and 3 months after transplantation. A significant increase in the tissue metabolism was detected in the MSC-treated but not in the BM-MNC-treated hearts when all 17 segments were analyzed (mean ± SD, **p < 0.01) (A) and also when only the infarcted ones were analyzed (*p < 0.05) (B). Representative images (cross and longitudinal views) of the hearts, 3 months after cell or medium injection, are shown (C). (Fig. 7A) . Furthermore, expression of this marker was not surprising, as MSC p < 0.01 vs. control; p < 0.01 vs. BM-MNC). The increase in macrophage infiltration in the BM-MNC-transdo express α-SMA in in vitro culture (data not shown). Cardiac contribution could not be detected by double planted animals was not due to the direct contribution of the transplanted cells as demonstrated by the lack of staining for GFP and the cardiac markers MLC2v or cTT (data not shown). CD68 + /GFP + cells. Furthermore, double staining for GFP and CD68 revealed a strong infiltration of macroIn order to confirm these data and identify the phenotypic identity of the mesenchymal cells once transphages in close contact with injected MSC (Fig. 5I-M) . Presence of GFP vesicles could be detected in the inplanted, electron microscopy after preembedding immunohistochemistry for GFP was performed. Four rats flammatory cells by immunofluorescence (Fig. 5M ) and confirmed by electronic microscopy (Fig. 6 ), suggesting sacrificed 1 or 2 weeks after injection were studied and a mean of 30 cells/rat were analyzed. Confirming the host cell-mediated immune rejection of the transplanted cells.
results obtained in the immunofluorescence analysis, no vascular or cardiac GFP-positive cells were found and
MSC Do Not Differentiate Towards Vascular or
GFP-positive cells showed a typical fibroblastic phenoCardiac Phenotypes In Vivo type with an elongated nucleus with a central nucleolus, small clumps chromatin organization, and a high density In vivo differentiation of MSC was analyzed by double immunofluorescence with antibodies against GFP of RER cisterns (Fig. 7B) . Implanted cells also presented big dictosomes and large mitochondrias and caand lineage-specific markers in tissue obtained at 1 and 2 weeks posttransplant. Transplanted MSC did not coloveoli (Fig. 7B, arrowheads) along their surface. Interestingly, a consistent collagen network was found around calize with endothelial markers such as caveolin-1, indicating lack of differentiation to endothelium (data not them (Fig. 7B, asterisks) .
On the other hand, although vascular or cardiac direct shown). On the other hand, although α-SMA-GFP cells Analysis of cell fate and in vivo proliferation. One and 2 weeks after transplant, heart sections were stained with antibodies against α-SM-actin-Cy3 and PCNA (Alexa-594: red) and GFP (Alexa-488: green). Nuclear staining was performed with TOPRO3 (blue). Expression of lineage-specific markers was tested by double immunofluorescence. Engrafted GFP-MSC were positive for α-SM-actin (higher magnification field: arrowheads) although remained as myofibroblasts and did not contribute to the vascular net (A). Proliferating GFP-positive MSC (arrowheads) were also observed surrounded by proliferating non-GFP cells (asterisks) (B). GFP-positive cells were identified after GFP immunogold staining as fibroblast-like cells, which were surrounded by areas of collagen deposition (asterisks). Top right: higher magnification showing a GFP-positive cell; bottom right: caveoli in the membrane of GFP-MSC (arrowheads) (C). Images were taken from animals sacrificed 1 week after treatment. Scale bars: (A, B) 25 µm; higher magnification (B): 10 µm; (C) 2 µm; top right: 400 nm; bottom right: 100 nm. contribution could not be detected, a small percentage of MSC: 897.1 ± 61.6 capillaries/mm 2 ; p < 0.05) (Fig. 9B-D) . On the other hand, both cell treatments induced an engrafted MSC (approximately 10% of engrafted cells at 1 week) did costained with PCNA (Fig. 7C , arrowincrease in big caliber vessels, quantified as α-SMApositive vessels/mm 2 (medium: 64.1 ± 5.4; BM-MNC: heads), indicating their ability to proliferate within the damaged tissue. GFP cycling cells were not detected 130.1 ± 11; MSC: 145.7 ± 7.8; p < 0.01 in both celltreated groups vs. medium) and α-SMA-positive area after 2 weeks posttransplant, suggesting either that proliferation occurred during a short time or that immune (medium: 1.2 ± 0.1%; BM-MNC: 2.09 ± 0.14%; MSC: 2.53 ± 0.15%; p < 0.01 in both cell-treated groups vs. rejection was involved in the lack of proliferating cells. Interestingly, non-GFP cells located in the area of injecmedium). Importantly, such increase in arterioles/arteries density in the peri-infarct region was significantly tion also expressed PCNA (Fig. 7C, asterisks) , suggesting an (auto)paracrine effect of the MSC that promotes higher in the animals treated with MSC than in the BM-MNC-treated animals ( p < 0.01 MSC vs. BM-MNC) cell proliferation. Although most proliferating cells were of hematopoietic lineage (not shown), cell-implanted an- (Fig. 9E-H ).
As together with the revascularization processes, tisimals also showed a marked increase in the density of endothelial-proliferating cells both in the peri-infarct sue remodeling may have an important role in the functional benefits. We analyzed infarct size and collagen and infarct regions in the groups of animals treated with MSC (peri-infarct: 1 week: 69.44 ± 13 cells/mm 2 ; 2 content in the treated versus control animals and, as shown in Figure 9I In this study, the rigorous comparison of the longterm effect of two bone marrow derived populations, after injection (17.49 ± 6.08 cells/mm 2 ; p < 0.05 vs. medium). Representative images are shown in Figure 8B .
BM-MNC and MSC, in a chronic model of myocardial infarction indicates that transplantation of both BM stem No proliferating endothelial cells, myofibroblasts, or smooth muscle cells were detected 1 or 2 weeks after cell populations induced a similar functional improvement but, importantly, that MSC induced a greater effect media injection (6 and 7 weeks after myocardial infarction) in animals treated with media alone.
in the injured hearts that resulted in a smaller infarct size and scar collagen content with an increase in revascu-MSC Promotes Revascularization larization of the tissue. These effects eventually correand Cardiac Remodeling lated with an increased tissue metabolism and a functional improvement in the contractile capacity of the Despite the low engraftment rate and the lack of differentiation, a functional benefit was detected in the rats myocardium. Different factors might be responsible for the supetransplanted with bone marrow-derived cells, with a stronger benefit in the animals treated with MSC. In orrior effect of the MSC over the BM-MNC, including a direct cell contribution to the vascular or cardiac tissue der to elucidate the mechanisms involved in such functional improvement, we analyzed the effect of treatment and/or a positive trophic effect. In accordance with previous studies with different populations of stem cells in on angiogenesis and vasculogenesis. Capillary density was determined 3 months after injection, by quantifying which the limited cell engraftment supports a paracrine effect as the responsible for the functional benefit (27-the small-caliber caveolin-1-positive vessels/mm 2 present in the peri-infarct region. As depicted in Figure 9A , 29), neither BM-MNC nor MSC could be detected after 2 weeks posttransplantation, which discards a long-term only transplantation of MSC was able to induce a significant increase in vessel count (medium: 683.9 ± 37. but a direct contribution to the vascular or cardiac tissue could be explained by the differences in the protocol model such as cell dose (five times higher in the cited was ruled out as no differentiated cells were found. Some other studies, but not all, have reported cardiovasstudy), duration of follow-up (6 weeks vs. 3 months) and, most importantly, timing of cell transplantation. cular differentiation of MSC (6, 58) but it is still not clear if the reported putative cardiac differentiation was due Several factors differentiate the acute versus the chronic stage, like inflammation, fibrosis, or tissue remodeling to fusion events (5) . Thereby, our results support an indirect trophic induction, as previously reported (28, 50) [reviewed in (14, 23) ] and could explain the differential effect of transplanted cells with a stronger inflammain several in vivo models of acute ischemia (10, 15, 20, 52, 60, 61, 64 ) and wound healing (11) .
tory/angiogenic effect of transplanted mononuclear cells in the acute stage versus a more potent effect in the tisDifferences in the cytokines expressed by each cell population or even the longer period of time in which sue remodeling of the mesenchymal cells at the chronic stage. Therefore, our results highlight the clinical implicells were detected in the heart might explain the differences observed between the effects of BM-MNC and cations for the selection of the cell type according to the underlying disease. MSC. Interestingly, a recent comparative study performed in a rodent acute model of MI (59) has shown a On the other hand, despite of the positive and promising long-term results obtained, the poor survival of the better functional income of BM-MNC-than MSCtreated animals. These apparently contradictory results cells remains as the main limitation of the study. A harsh scar tissue environment and the immunogenicity of the ence of cells in the injured tissue. On top of the GFP response, the MNC bone marrow fraction may contain GFP are potential factors explaining the rapid cell disappearance. We have to consider that, in our model, immature immune cells and precursors that could elicit a stronger immune response. On the other hand, MSC has munosuppression with cyclosporin A inhibited T-cellmediated response but not monocyte/macropages action, been reported to exert an immunomodulatory effect, which could have delayed or blunted the process (31) . which can react against the GFP neoantigen as we have demonstrated in this study and consistent with previous Improvement of cell engraftment remains a major goal for cell therapy. In fact, several reports have shown a reports (33) . In the case of the BM-MNC, which elicited a remarkable inflammatory response, the effect could be greater benefit when MSC were genetically modified by, for example, transfection of vectors that overexpressed faster than with the MSC, paying for the shorter pres-the Akt protein or the hypoxia-regulated heme oxygencytic, proteolytic, and inflammatory functions, while during a later phase, monocytes promote healing via myase 1 (38, 55) or when administered together with cytokine cocktails (i.e., IGF-1) (12,17) that favored their surofibroblast accumulation, angiogenesis, and deposition of collagen (46) . The potential of monocytes/macrovival once transplanted. A different approach has used MSC grown in vitro over matrices that can be applied phages to contribute to healing of the myocardium has also been described in recent studies (7, 11, 18) . Transto the myocardium, thereby facilitating their engraftment (44) . These strategies should be able to improve cell replanted cells may in fact increase these processes by stimulating the recruitment of more inflammatory cells. tention and survival or even promote the differentiation of the cells towards desired cell phenotypes.
Whether macrophage infiltration is due to the release of growth factors or to an immune-mediated rejection proAnother interesting finding related to the potential mechanism of tissue repair after cell therapy was the cess as mentioned above cannot be ruled out, but in any case may contribute to the beneficial effect. The greater induction of proliferation of host cells. It is conceivable that the release of growth factors such as VEGF, HGF, macrophage infiltrate observed after BM-MNC could also be responsible for the faster clearance of the cells and bFGF could contribute to cell proliferation and cell survival, consistent with previous studies with MSC (2, and should be taken into account as most of the clinical trials performed with stem cells have been performed 47, 56) , while the release of SDF1 (63) could stimulate BM progenitor cell homing (1). Our study supports the with bone marrow-derived mononuclear cells. In summary, we conclude that transplantation of role of transplanted cells in the in vivo induction of proliferation of host cells such as endothelial and smooth MSC provide a long-term beneficial effect in cardiac function and remodeling even when hearts are chronimuscle cells, as previously described in vitro (28,29). Despite cell proliferation being a short-term effect (we cally injured, despite the lack of direct contribution of the transplanted cells. Furthermore, this is the first study could only observed a significant proliferation for up to 2 weeks after transplant but not at 1 at 3 months), the where the potential of MSC and freshly isolated BM-MNC has been comparatively studied in a chronic effects were long term, as demonstrated by the increase in angiogenesis and vasculogenesis for up to 3 months model, showing that despite some positive effect in cardiac performance by BM-MNC, MSC had a clear supeposttransplantation. It is important to note that no cell proliferation was found in animals in which only media rior effect. We believe that given the demonstrated potential of the MSC, it should be a population to consider was administered, consistent which the fact that the acute MI was induced more that 7 weeks before, a pefor future clinical trials not only in the acute but also in the chronic setting of the disease. riod of time in which healing of the myocardium in rats has ensued. In addition, our results showing the induc- the proinflammatory microenvironment provided by the REFERENCES CD68 + cell infiltration could stimulate an antifibrotic phenotype of the cardiac fibroblasts (8) .
